Join in the fight against the second most common cancer across both men and women in Singapore with 365 Cancer Prevention Society’s (365CPS) #My1stColonoscopy free screening campaign. Now in its fourth year, this initiative – jointly organised by 365CPS and Icon Cancer Centre, provides seamless access to sponsored colonoscopy for lower-income individuals aged between 45 to 70 from now to 30 April 2025.
Colorectal cancer is a type of cancer that starts in the colon, residing in the large intestine. It is sometimes referred to as colon cancer or rectal cancer, depending on where it starts. According to the Singapore Cancer Registry Annual Report 2022 released by the National Registry of Diseases Office in September 2024, it is the second most commonly diagnosed cancer among both men and women in Singapore, with approximately 1,400 new cases each year. The overall lifetime risk of developing colorectal cancer in the country is around 5.6%.
Colorectal cancer is often a silent disease which presents no symptoms in the early stages. When symptoms do occur, they may include rectal bleeding or blood in stools, persistent diarrhoea or constipation, abdominal discomfort, unexplained weight loss or constant fatigue. Regular screening is crucial, as colorectal cancer is one of the most preventable and treatable cancers when detected early. Screening also aids in identifying and removing pre-cancerous polyps before they develop into cancer.
Sign-Up for #My1stColonoscopy Free Colorectal Cancer Screening Programme
For any enquiries or to register for #My1sColonoscopy, members of the public can contact 365CPS community partners or register on 365CPS website at the link provided.
Screening eligibility:
– 45 to 70 years old
– Valid blue or orange CHAS card or Public Assistance (PA) card
– Have not done a colonoscopy in the last five years
#My1stColonoscopy is jointly organised by 365CPS and Icon Cancer Centre to take an active step towards the fight against colon cancer. It is made possible through 365CPS partnership with various community groups, medical partners and social service agencies to identify and encourage at-risk beneficiaries to undergo the sponsored screening.
